Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 103: 376-377, 2007. First published April 19, 2007; doi:10.1152/japplphysiol.00414.2007
8750-7587/07 $8.00
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/1/376    most recent
00414.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Febbraio, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Febbraio, M. A.

EDITORIAL

HIGHLIGHTED TOPIC
Exercise and Inflammation

Exercise and inflammation

THE PURPOSE OF THIS REVIEW series is to highlight the tremendous advancement in knowledge that has taken place over the last five to ten years regarding the interaction between physical exercise and inflammation. Many years ago, it was recognized that regular, moderate exercise reduced the risk of infection compared with a sedentary lifestyle, whereas prolonged, heavy intensity exercise increased infection risk; the so called "J-shaped model" (16). However, the precise nexus between physical activity, inflammation, and immunity has, until recently, been unknown, as studies in this area, and the conclusions they made, were largely based on descriptive data analysis. Indeed, in a comprehensive review on exercise and immune function, published at the turn of the millennium, Pedersen and Hoffman Goetz (18) recognized this and commented, "The focus of future work in exercise immunology should move beyond descriptive, phenomenological studies to studies of underlying neural, hormonal, cytokine, and biochemical mechanisms for the observed effects." It must be said that researchers in the field have heeded this message, and this can be clearly observed from the present review series.

In the first of the series, Gleeson (7) reviews the literature relating to immune function in sport and exercise. One new and exciting development in this field, from work conducted in Dr. Gleeson's laboratory, is the role that Toll-like receptors (TLRs) play in the immune response in humans during exercise. TLR's are an evolutionary, conserved family of pattern recognition receptors known to play an essential role in detecting infection in both Drosophila and mammals (9). In a paper by Lancaster et al. (13), the authors demonstrated that physical activity decreased the expression of TLR1, TLR2, and TLR4 and concluded that TLR function is subject to modulation under physiological conditions in vivo. Intriguingly, physical exercise is known to increase circulating heat shock proteins (23), which are known to activate TLR2 and TLR4 (1), highlighting the complexity of the immune system in response to physical exercise. The theme of exercise and immune function is continued in the review by Cooper (4), who proposes the theory that exercise elicits an immunological danger type of stress that, on occasions, becomes dysregulated and detrimental to well-being. This view is consistent with that of Matzinger (14), who was the first to challenge the "self versus non-self" theory of immune function, a proposed model of immunity based on the idea that the immune system is more concerned with molecules that do damage rather than those that are foreign. In his review, Dr. Cooper provides various instances of the "danger theory" in the context of strenuous exercise. For example, he points out that food-sensitizing immune cells are relatively innocuous in homeostasis. However, in cases of exercise anaphylaxis, these cells are redistributed from depots such as the spleen into the central circulation where they are no longer harmless.

The other reviews in this series center on the role of the contracting skeletal muscle in the interaction between exercise and inflammation. It is in this area that a tremendous amount of knowledge has been obtained in recent years, and the muscle can no longer be regarded as the organ whose role is purely to allow for locomotion. In their review, Pedersen and colleagues (17) suggest that, like the adipose tissue that produces adipokines that circulate and affect metabolic processes (20), skeletal muscle produces "myokines" that also affect metabolism. This work was largely based on important findings that skeletal muscle is the site for production of the cytokine interleukin-6 (IL-6; Ref. 88), contracting muscle releases this cytokine into the circulation (21), and during exercise the release of this cytokine is one of the so-called "work factors" that modulates hepatic glucose production during physical exercise (5). On the basis of the papers by Pedersen and her coworkers, the authors argue that the skeletal muscle can now be viewed as an endocrine organ. The authors provide a review of recent papers from both their group and others that show that other interleukins, namely IL-8 and IL-15, are also produced by skeletal muscle.

What leads to cytokine production in skeletal muscle with the onset of contraction? In the next review article (11), Kramer and Goodyear (11) present an informative review that suggests that two major signal transduction pathways, namely the mitogen-activated protein kinases (MAPK) and nuclear factor-{kappa}B (NF-{kappa}B), are upregulated by muscle contraction. In their review the authors suggest that during low-intensity exercise, contraction activates the extracellular signal-regulated kinases (ERK1/2), which enhance fat metabolism, possibly via the recruitment of the putative fatty acid transporter CD36 (22). In contrast, during heavy activity, p38 MAPK is activated and leads to the upregulation of various metabolic genes via activation of key transcription factors myocyte enhancing factor (MEF)-2 and activating transcription factor (ATF)-2. Next, the authors review the literature relating to NF-{kappa}B, which is known as the master controller of inflammation and critical to the life and/or death of a cell (10). Drs. Kramer and Goodyear point out that activation of NF-{kappa}B can be paradoxical, resulting in health benefits in some circumstances and disease in others. In doing so, this review highlights some important questions that suggest that NF-{kappa}B in skeletal muscle may indeed be unique when compared with other tissues or organs or cells. Why, for example does chronic activation of the upstream kinase, I Kappa kinase (IKK), result in profound insulin resistance and production of IL-6 in liver (3), whereas no such effects are seen in skeletal muscle (2)? It may well be because skeletal muscle is dynamic and undergoes rapid homeostatic alterations during contraction, and, as such, evolution has allowed for it to be protected against such disruption to homeostasis.

Finally, Frost and Lang (6) review the literature with respect to the role of acute transforming retrovirus thymoma (Akt), also known as protein kinase B (PKB). This is indeed an heroic task as there are three isoforms of this kinase (Akt1–3); multiple inputs into activation, including growth factor receptors, nutrients, and muscle contraction per se; and several downstream targets associated with anabolism and nutrient delivery to the cell. One section of their review that is both thought provoking and important is the role of Akt in the regulation of the important transcriptional coactivator, peroxisome proliforator-activated receptor gamma coactivator (PGC)-1{alpha}. In skeletal muscle, PGC-1{alpha} inhibits the expression of atrogenes MuRF-1 and MAFbx (19), and it is known that PGC-1{alpha} expression is reduced in diseases such as Type 2 diabetes (15). During exercise, PGC-1{alpha} expression is increased (24), and, importantly, in a recent study, treatment of mice with resveratrol, a polyphenol found in red wine and known to extend life span in Drosophila and Caenorhabdtis elegans (25), protected mice against diet-induced obesity and insulin resistance (12). Importantly, in this recent study (12), the authors were able to show that the effects of resveratrol were largely mediated by increased activation of PGC-1{alpha}. Could it be that much of the beneficial health effects of exercise are due to the upregulation of PGC-1{alpha} in muscle by contraction? These questions and many others are raised by this comprehensive series of reviews published in this Highlighted Topic series in the Journal of Applied Physiology.

Mark A. Febbraio

Cellular and Molecular Metabolism Laboratory
Diabetes and Metabolism Division
Baker Heart Research Institute
Victoria, Australia


Address for reprint requests and other correspondence: M. A. Febbraio, Cellular & Molecular Metabolism Laboratory, Diabetes & Metabolism Division, Baker Heart Research Institute, PO Box 6492 St Kilda Road Central VIC, 8008, Australia (e-mail: mark.febbraio{at}baker.edu.au)

FOOTNOTES


Address for reprint requests and other correspondence: M. A. Febbraio, Cellular & Molecular Metabolism Laboratory, Diabetes & Metabolism Division, Baker Heart Research Institute, PO Box 6492 St Kilda Road Central VIC, 8008, Australia (e-mail: mark.febbraio{at}baker.edu.au)

REFERENCES

  1. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277: 15028–10534, 2002.[Abstract/Free Full Text]
  2. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Shoelson SE. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285–298, 2004.[CrossRef][Web of Science][Medline]
  3. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11: 183–190, 2005.[CrossRef][Web of Science][Medline]
  4. Cooper DM. Dangerous exercise—lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol. In press; doi:10.1152/japplphysiol.00225.2007.
  5. Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis in skeletal muscle contraction. Diabetes 53: 1643–1648, 2004.[Abstract/Free Full Text]
  6. Frost RA, Lang CH. Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol. In press; doi:10.1152/jappl.00089.2007.
  7. Gleeson M. Immune function in sport and exercise. J Appl Physiol. In press; doi:101152/japplphysiol.00008.2007.
  8. Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA. Skeletal myocytes are the source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 18: 992–994, 2004.[Abstract/Free Full Text]
  9. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 20: 197–216, 2002.[CrossRef][Web of Science][Medline]
  10. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221–227, 2002.[CrossRef][Web of Science][Medline]
  11. Kramer HF, Goodyear LJ. Exercise, MAPK, and NF-{kappa}B signaling in skeletal muscle. J Appl Physiol. In press; doi:10.1152/japplphysiol.00085-2007.
  12. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109–1122, 2006.[CrossRef][Web of Science][Medline]
  13. Lancaster GI, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT, Gleeson M. The physiological regulation of toll-like receptor expression and function in humans. J Physiol 563: 945–955, 2005.[Abstract/Free Full Text]
  14. Matzinger P. The danger model: a renewed sense of self. Science 296: 301–305, 2002.[Abstract/Free Full Text]
  15. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. PGC-1{alpha} responsive genes involved in oxidative phosphorylation are co-ordinately downregulated in human diabetes. Nat Genet 34: 267–273, 2003.[CrossRef][Web of Science][Medline]
  16. Nieman DC. Exercise, infection, immunity. Int J Sports Med. 15, Suppl 3: S131–S141, 1994.[Web of Science][Medline]
  17. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol. In press; doi:10.1152/japplphysiol.00080.2007.
  18. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80: 1055–1081, 2000.[Abstract/Free Full Text]
  19. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103: 16260–16265, 2006.[Abstract/Free Full Text]
  20. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55: 1537–1545, 2006.[Abstract/Free Full Text]
  21. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529: 237–242, 2000.[Abstract/Free Full Text]
  22. Turcotte LP, Raney MA, Todd MK. ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle. Acta Physiol Scand 184: 131–139, 2004.[CrossRef][Web of Science]
  23. Walsh RC, Koukoulas I, Garnham A, Moseley PL, Hargreaves M, Febbraio MA. Exercise increases serum HSP72 in humans. Cell Stress Chaperon 6: 386–393, 2001.[CrossRef][Web of Science][Medline]
  24. Watt MJ, Southgate RJ, Holmes AG, Febbraio MA. Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. J Mol Endocrinol 33: 533–544, 2004.[Abstract/Free Full Text]
  25. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686–689, 2004.[CrossRef][Medline]




This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
103/1/376    most recent
00414.2007v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Febbraio, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Febbraio, M. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.